Global Data Shows that Mortality from Viral Hepatitis B and C in Africa is Becoming a Major Threat- World Health Organization.
Source: Centers for Disease Control and Prevention, 2019.
Accessible at: Global Viral Hepatitis: Millions of People are Affected | CDC
In Africa, efforts to prevent and control viral hepatitis have improved (World Health Organization, 2017). However,despite this improvement, attention is needed to eradicate hepatitis B and C. This is because 95% of hepatitis morbidity and mortality remain attributable to hepatitis B and C (WHO, n.d.).
Daily, over 300 people are at risk of contracting viral hepatitis B and C globally, and over 3,000 deaths are attributable to viral hepatitis-related liver diseases (World Health Organization, 2022).
Globally in 2019, there were:
- 296 million people living with hepatitis B
- 58 million people living with hepatitis C
- 1.5 million new cases of chronic hepatitis B (Centre for Disease Control and Prevention, 2021).
Currently, at least 91 million cases of Hepatitis B or C are Africans (World Health Organization, 2022). Despite the availability of diagnostic tools and effective treatment, over 90% of people living with hepatitis B and C in Africa don’t have access to the care they need (World Health Organization, 2022).
Quoting the words of Dr. Matshidiso Moeti, The WHO African Regional Director: ‘‘Hepatitis has been called the silent epidemic, but this scorecard is sounding an alarm for the region and the world to hear.’’
How can we help eradicate hepatitis B and C in Africa?